Dividends
Dividend payments are $3.26 per share, with a current dividend yield of 1.58%. The company has dividend history for 14 consecutive years.
DGX Dividend Summary
1.58%
$3.26
36.02%
27.29%
Consecutive Years
14
Next Ex-Dividend Date
Jul 8, 2026
Next Payment Date
Jul 22, 2026
DGX Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
DGX Dividends CAGR Chart
Quest Diagnostics Incorporated (DGX)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2026(YTD) | $2.52 | — |
| 2025 | $3.15 | +6.42% |
| 2024 | $2.96 | +6.09% |
| 2023 | $2.79 | +7.31% |
| 2022 | $2.60 | +7.44% |
| 2021 | $2.42 | +9.50% |
| 2020 | $2.21 | +4.25% |
| 2019 | $2.12 | +8.72% |
| 2018 | $1.95 | +8.33% |
| 2017 | $1.80 | +13.92% |
| 2016 | $1.58 | +7.48% |
| 2015 | $1.47 | +13.95% |
| 2014 | $1.29 | +7.50% |
| 2013 | $1.20 | +76.47% |
| 2012 | $0.68 | +70.00% |
| 2011 | $0.40 | +0.00% |
| 2010 | $0.40 | +0.00% |
| 2009 | $0.40 | +0.00% |
| 2008 | $0.40 | +0.00% |
| 2007 | $0.40 | +2.56% |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q3 2026 | $0.86 | +7.50% |
| Q2 2026 | $0.86 | +7.50% |
| Q1 2026 | $0.80 | +6.67% |
| Q4 2025 | $0.80 | +6.67% |
| Q3 2025 | $0.80 | +6.67% |
| Q2 2025 | $0.80 | +6.67% |
| Q1 2025 | $0.75 | +5.63% |
| Q4 2024 | $0.75 | +5.63% |
| Q3 2024 | $0.75 | +5.63% |
| Q2 2024 | $0.75 | +5.63% |
| Q1 2024 | $0.71 | +7.58% |
| Q4 2023 | $0.71 | +7.58% |
| Q3 2023 | $0.71 | +7.58% |
| Q2 2023 | $0.71 | +7.58% |
| Q1 2023 | $0.66 | +6.45% |
| Q4 2022 | $0.66 | +6.45% |
| Q3 2022 | $0.66 | +6.45% |
| Q2 2022 | $0.66 | +6.45% |
| Q1 2022 | $0.62 | +10.71% |
| Q4 2021 | $0.62 | +10.71% |
| Q3 2021 | $0.62 | +10.71% |
| Q2 2021 | $0.62 | +10.71% |
| Q1 2021 | $0.56 | +5.66% |
| Q4 2020 | $0.56 | +5.66% |
Dividend Yield Metrics
- Current Yield
- 1.58%
- Average Yield (TTM)
- 1.58%
- Average Yield (3Y)
- 1.44%
- Forward Yield on Cost (3Y)
- 2.06%
- Forward Yield on Cost (5Y)
- 2.45%
- Forward Yield on Cost (10Y)
- 3.81%
Payout Ratio Analysis
- Payout Ratio (Current)
- 36.02%
- FCF Payout Ratio
- 27.29%
- Payout Ratio (3Y Avg)
- 36.74%
- Payout Ratio (5Y Avg)
- 31.49%
- FCF Payout (3Y Avg)
- 32.68%
- FCF Payout (5Y Avg)
- 27.50%
Dividend Coverage
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis